Development of a validated LC-ESI-MS/MS method for the quantification of tucatinib in plasma samples
Journal of Applied Pharmaceutical Science · 2026-05 · 16 (5) · 169-175
DOI: 10.7324/japs.2025.213916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Pharmaceutical Science, online erschienen am 01.05.2026. Verfasst von Sunil Dattatray Pawar und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pawar, S. D., Kayande, D. D., Pawar, K., Farooqui, M., Shankarwar, A., Deshpande, A., & Shankarwar, S. (2026). Development of a validated LC-ESI-MS/MS method for the quantification of tucatinib in plasma samples. Journal of Applied Pharmaceutical Science, 16(5), 169-175. https://doi.org/10.7324/japs.2025.213916
Vancouver
Pawar SD, Kayande DD, Pawar K, Farooqui M, Shankarwar A, Deshpande A, et al. Development of a validated LC-ESI-MS/MS method for the quantification of tucatinib in plasma samples. Journal of Applied Pharmaceutical Science. 2026;16(5):169-175. doi:10.7324/japs.2025.213916
BibTeX
@article{Pawar2026,
author = {Pawar, Sunil Dattatray and Kayande, Deepak D. and Pawar, Kokila and Farooqui, Mazahar and Shankarwar, Anil and Deshpande, Amol and Shankarwar, Sunil},
title = {Development of a validated LC-ESI-MS/MS method for the quantification of tucatinib in plasma samples},
journal = {Journal of Applied Pharmaceutical Science},
year = {2026},
volume = {16},
number = {5},
pages = {169--175},
doi = {10.7324/japs.2025.213916}
}
EUVIMED